KCT0001023
Recruiting
未知
Development of molecular diagnostic markers using oral fluid for diagnosis of periodontitis in diabetes : a pilot study
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Diseases of the musculo-skeletal system and connective tissue
- Sponsor
- Asan Medical Center
- Enrollment
- 24
- Status
- Recruiting
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •A. Periodontal Disease
- •\- Patients with chronic periodontitis
- •\- Patients required primary treatment of periodontal scaling, subgingival curettage, and agreed agreed with the basic periodontal therap based on the standard protocol
- •\- subjects agreed collecting saliva and gingival crevicular fluid and physicochemical tests and genetic testing
- •B. Diabetics
- •Satisfy one of the following three
- •1\) The typical symptoms of diabetes ( polyuria, erudite , dagal , unexplained weight loss) while blood glucose levels are 200 mg / dL or higher
- •2\) fasting plasma glucose concentration was 126 mg / dL or higher
- •3\) glucose tolerance test glucose levels 2 hours after the load (PP2, 2 hrs post\-prandial plasma glucose level) is more than 200mg/dL
- •\- subjects agreed collecting saliva and gingival crevicular fluid and physicochemical tests and genetic testing
Exclusion Criteria
- •\- Received periodontal treatment within the last six months
- •\- recently taken antibiotics within 3 months if you need a prescription antibiotic prophylaxis
- •\- taking the drug can affect periodontal status for a long period of time
- •\- pregnant or breastfeeding
- •\- In case of oral inflammatory mucosal disease (Lichen planus, etc.)
- •\- Patients with a history of alcoholism or drug abuse
- •\- other special systemic disease (high blood pressure)
- •\- ages under 18
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Evaluation and survey of malaria chemoprevention drug resistance in infant from Koutiala, MaliPACTR202401827533382AAS1,000
Recruiting
Not Applicable
Molecular markers for diagnosis and therapy response in Inflammatory Bowel diseases: A prospective population based bio-bank of inflammatory bowel disease patients in Zuid Limburg, The Netherlands.inflammatory bowel disease10017969NL-OMON50587Interne geneeskunde/Divisie MD5,000
Not yet recruiting
Phase 3
Evaluation of levels of Biomarkers in different stages of PulpitisHealth Condition 1: K040- PulpitisCTRI/2023/11/059706Manipal College of Dental Sciences
Not yet recruiting
Not Applicable
Evaluation of the Pneumonia plus panel for the identification of pathogens and modification of antibiotics in patients with lower respiratory infections at a tertiary centreCTRI/2023/07/055679Aster Medcity Cochin
Not yet recruiting
Not Applicable
Establishment of new diagnostic Biomarker and Characterization of protective bone marrow niche in patients with multiple myelomaC90Multiple myeloma and malignant plasma cell neoplasmsDRKS00010830niversitätsklinikum Freiburg160